ATRS News and Press, Antares Pharma Inc. From 04/13/22

Gainers: Kaleido Biosciences (KLDO) +114%. Antares Pharma (ATRS) +49%. Sierra Oncology (SRRA) +39%. HighPeak Energy (HPK) +29%. Biofrontera (BFRI) +30%. Turning Point Therapeutics (TPTX) +27%. Aterian (ATER) +25%. Hallador Energy (HNRG) +23%. Crinetics Pharmaceutical (CRNX) +20%. Exscientia (...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Late-stage biopharmaceutical company Sierra Oncology (NASDAQ: SRRA ) is up big today on news that GlaxoSmithKline (NYSE: GSK ) will purchase the business . Indeed, SRRA stock is up a massive 38% so far today on...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Antares Pharma (NASDAQ: ATRS ) stock is rocketing higher on Wednesday after the pharmaceutical company reached an acquisition agreement with Halozyme Therapeutics (NASDAQ: HALO ). Source: Shutterstock Th...

Gainers: Antares Pharma ATRS +49%. Sierra Oncology SRRA +38%. CTI BioPharma (CTIC) +8%. Ikena Oncology IKNA +8%. Modular Medical (MODD) +4%. Losers: NanoString Technologies NSTG -31%. Bio-Path (BPTH) -17%. BioCardia (BCDA) -14%. Biod...

Top Penny Stocks News on April 13th After Tuesday posed a bearish turnaround for penny stocks and blue chips at midday, investors are hopeful that Wednesday could be different. In the past few trading days, we’ve seen a sizable amount of volatility for penny stocks . This is ...

Shares of the drug delivery specialist Antares Pharma (NASDAQ: ATRS) jumped by as much as 49.2% in premarket action Wednesday morning. The company's stock is bolting higher in response to a $960 million definitive merger agreement with Halozyme (NASDAQ: HALO) . Per the t...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Join me today as we break down all the news behind the biggest pre-market stock movers for Wednesday! Source: f11photo/Shutterstock.com Moving stocks this morning are earnings reports, acquisition deals, insider buy...

Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader PR Newswire Transaction Expected to be Immediately Accretive to Revenue and Non-GAAP Earnings in 2022 with Multiple Drivers to Accelerate Financial Growth Through 2027 and Bey...

Antares Pharma Inc. (NASDAQ:ATRS) traded at a new 52-week high today of $5.15. So far today approximately 136.1 million shares have been exchanged, as compared to an average 30-day volume of 935,000 shares. Antares Pharma Inc is a specialty pharmaceutical company. It is focused on the de...

The commercial-stage pharma company, Antares Pharma (NASDAQ:ATRS), announced that the U.S. Food and Drug Administration (FDA) granted the final approval for TLANDO (testosterone undecanoate). An oral form of testosterone replacement therapy, TLANDO, is indicated for adults with hypogonadism, ...